Indoco Launches Favipiravir Under Brand Name FEVINDO 400 In India
Published On 28 Sep 2q020 1:00 PM | Updated On 28 Sep 2020 1:01 PM
qqqqqq
Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better
patient compliance.
Mumbai: Drugmaker, Indoco Remedies, has recently announced the launch of FEVINDO (Favipiravir)
400 mg Tablets in India.
Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient
compliance.
Fevindo - 400 (Favipiravir) is an antiviral drug, effective against the RNA-based
influenza virus.
The drug has been approved by DCGI in the treatment of Covid-19.
Fevindo 400 reduces pill burden by 50% and ensures convenient dosing and better patient compliance.
Ms. Aditi Kare Panandikar, Managing Director - Indoco Remedies Ltd. commented,
"The Covid-19 crisis has created vast disruption to life in India and all over the globe. As part of pharma industry,
we have been able to do our bit in prevention of Covid-19 with our brands Karvol Plus, ATM, Febrex Plus and Rexidin SRS
Mouthwash. With the launch of FEVINDO, we are taking the next step from prevention to the treatment of Covid-19."
|